This is a Validated Antibody Database (VAD) review about mouse Cdk4, based on 68 published articles (read how Labome selects the articles), using Cdk4 antibody in all methods. It is aimed to help Labome visitors find the most suited Cdk4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cdk4 synonym: Crk3

Invitrogen
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to determine the concordance between two methods to detect cases of atypical lipomatous tumor/well-differentiated liposarcoma, Invitrogen Cdk4 antibody (Invitrogen, AHZ0202) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Am J Surg Pathol (2016) ncbi
mouse monoclonal (DCS-31)
  • western blot; rat; 1:1000; fig 4
In order to study the correlation between glutamate-induced neurotoxicity and expression of cell cycle proteins in cortical neurons, Invitrogen Cdk4 antibody (Invitrogen, AHZ0202) was used in western blot on rat samples at 1:1000 (fig 4). Biofactors (2016) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; 1:1000; fig 2
In order to study prostate cancer DU145 cells and anti-tumor activity of the TRPM8 inhibitor BCTC, Invitrogen Cdk4 antibody (Neomarkers, MS-299-P0) was used in western blot on human samples at 1:1000 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; fig s4
In order to identify mutations in desmoplastic melanoma samples, Invitrogen Cdk4 antibody (Invitrogen, AHZ0202) was used in immunohistochemistry on human samples (fig s4). Nat Genet (2015) ncbi
mouse monoclonal (DCS-31)
  • western blot; human; fig 5
In order to analyze sensitivity to the cyclin D1/CDK4 pathway inhibition in Ewing sarcoma by a chemical genomic, functional, and super-enhancer screening, Invitrogen Cdk4 antibody (Thermo Fisher Scientific, MS-469-P0) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human
In order to investigate the frequency and contribution of HMGA2, CDK4, and JUN to dedifferentiated liposarcomas and atypical lipomatous tumors/well-differentiated liposarcomas, Invitrogen Cdk4 antibody (Biosource International, DCS 31) was used in immunohistochemistry on human samples . Mod Pathol (2015) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:50
In order to characterize a primary myxoid liposarcoma with chondroid and osseous components, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:50. Appl Immunohistochem Mol Morphol (2015) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen Cdk4 antibody (Invitrogen, clone DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2015) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:100
In order to determine the role and diagnostic efficacy of RB1, CDK4, CHMP2B, HSP90, and cPLA2G4A as markers in myxofibrosarcomas and myxoid liposarcomas, Invitrogen Cdk4 antibody (Life Technologies, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Surg Pathol (2014) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human
In order to describe a woman showing an incidental hibernoma associated with a cortical adenoma producing primary hyperaldosteronism, Invitrogen Cdk4 antibody (Biosource International, DCS-31) was used in immunohistochemistry on human samples . Pathol Res Pract (2013) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; 1:700; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry on human samples at 1:700 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200. World Neurosurg (2014) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; 1:250; fig 4
In order to study the clinicopathological and genetic features of well-differentiated/dedifferentiated liposarcoma with prominent myxoid stroma, Invitrogen Cdk4 antibody (Invitrogen, DCS-31) was used in immunohistochemistry on human samples at 1:250 (fig 4). Histopathology (2013) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; fig 3
In order to assess if MDM2 copy number distinguishes lipomas from atypical lipomatous tumors, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples (fig 3). Mod Pathol (2012) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1.
In order to discuss markers that distinguish between different subtypes of osteosarcomas, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1.). Am J Surg Pathol (2012) ncbi
mouse monoclonal (DCS-31)
  • immunocytochemistry; human; 1:250; fig 8
In order to characterize malignant fat-forming solitary fibrous tumor, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunocytochemistry on human samples at 1:250 (fig 8). Am J Surg Pathol (2011) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; 1:50; fig 6
In order to examine expression of MDM2-CDK4 in low-grade osteosarcomas and fibrous or fibro-osseous lesions of the bone or paraosseous soft tissue, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples at 1:50 (fig 6). Mod Pathol (2011) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to use 9 cases of well-differentiated/dedifferentiated liposarcoma to characterize unappreciated features, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Am J Surg Pathol (2010) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to explore the use of MDM2 and CDK4 for the histological diagnosis of low-grade osteosarcoma, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Mod Pathol (2010) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:250; fig 6
In order to characterize 12 unusual liposarcomas, Invitrogen Cdk4 antibody (Biosource/Invitrogen, clone DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 6). Am J Surg Pathol (2010) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; fig 3
In order to study the significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples (fig 3). Clin Cancer Res (2009) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:100
In order to report genetic changes in dedifferentiated liposarcomas, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mod Pathol (2009) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; fig 2
In order to discuss a rare presentation of a lipoleiomyosarcoma and review the method of pathologic diagnosis, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples (fig 2). Am J Clin Oncol (2009) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry; human; tbl 2
In order to discuss the properties of desmoid tumors, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry on human samples (tbl 2). JOP (2008) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess if immunostaining for PPAR-gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mod Pathol (2008) ncbi
mouse monoclonal (DCS-35)
In order to study if the growth state-dependent tyrosine phosphorylation of p27Kip1 determines whether or not it inhibits cdk4, Invitrogen Cdk4 antibody (NeoMarkers, DCS-35) was used . Mol Cell Biol (2008) ncbi
mouse monoclonal (DCS-31)
  • western blot; human
In order to elucidate how treatment with gallotannin prevents cancer, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in western blot on human samples . Mol Carcinog (2007) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to present a unique case of relapsing retroperitoneal dedifferentiated liposarcoma with alpha-fetoprotein ectopic production, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Virchows Arch (2006) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 1
In order to present the case of a patient with a rare atypical lipomatous tumor with spindle cell features, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 1). Virchows Arch (2005) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - frozen section; human; 1:200; fig 3
In order to characterize dedifferentiated liposarcomas with an inflammatory malignant fibrous histiocytoma component, Invitrogen Cdk4 antibody (Biosource International, clone DCS-31) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 3). J Pathol (2004) ncbi
mouse monoclonal (DCS-31)
  • western blot; mouse; fig 2
In order to report that cicaprost regulates the expression of Skp2, Invitrogen Cdk4 antibody (BioSource, DCS-31) was used in western blot on mouse samples (fig 2). J Biol Chem (2004) ncbi
mouse monoclonal (DCS-31)
  • immunohistochemistry - paraffin section; human
In order to report that most so-called malignant fibrous histiocytomas from the retroperitoneum are dedifferentiated liposarcoma, Invitrogen Cdk4 antibody (Biosource, DCS-31) was used in immunohistochemistry - paraffin section on human samples . Mod Pathol (2003) ncbi
Santa Cruz Biotechnology
mouse monoclonal (DCS-35)
  • ELISA; human; 10 ug/ml; fig 3b
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-23896) was used in ELISA on human samples at 10 ug/ml (fig 3b). BMC Biotechnol (2021) ncbi
mouse monoclonal (DCS-31)
  • western blot; human; loading ...; fig 8d, 8e
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-56277) was used in western blot on human samples (fig 8d, 8e). Cancer Cell Int (2021) ncbi
mouse monoclonal (DCS-35)
  • western blot; mouse; 1:300; fig 5a
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-23896) was used in western blot on mouse samples at 1:300 (fig 5a). J Cell Mol Med (2021) ncbi
mouse monoclonal (DCS-35)
  • western blot; rat; 1:200; loading ...; fig 5b
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-23896) was used in western blot on rat samples at 1:200 (fig 5b). Int J Nanomedicine (2020) ncbi
mouse monoclonal (3F121)
  • western blot; human; loading ...; fig 3f
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-70831) was used in western blot on human samples (fig 3f). Mol Cancer (2020) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; loading ...; fig 5g
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-23,896) was used in western blot on human samples (fig 5g). J Exp Clin Cancer Res (2019) ncbi
mouse monoclonal (0.N.199)
  • western blot; human; 1:1000; loading ...; fig 1e
Santa Cruz Biotechnology Cdk4 antibody (Santa, sc-70832) was used in western blot on human samples at 1:1000 (fig 1e). Aging (Albany NY) (2019) ncbi
mouse monoclonal (B-10)
  • western blot; mouse; loading ...; fig 5d
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, B-10) was used in western blot on mouse samples (fig 5d). Sci Rep (2019) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-23896) was used in western blot on human samples (fig 3a). Cell Rep (2019) ncbi
mouse monoclonal (DCS-31)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology Cdk4 antibody (SantaCruz, sc-56277) was used in western blot on human samples (fig 2b). Mol Cell (2017) ncbi
mouse monoclonal (97)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology Cdk4 antibody (SantaCruz, sc-136241) was used in western blot on human samples (fig 5c). Oncogene (2017) ncbi
mouse monoclonal (3F121)
  • immunoprecipitation; human; 1:50; loading ...; fig 5f
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-70831) was used in immunoprecipitation on human samples at 1:50 (fig 5f) and in western blot on human samples (fig 5f). Nat Commun (2017) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; 1:200; loading ...; fig 5a
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-23896) was used in western blot on human samples at 1:200 (fig 5a). Oncotarget (2017) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; 1:500; loading ...; fig 5h
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-23896) was used in western blot on human samples at 1:500 (fig 5h). Nat Commun (2017) ncbi
mouse monoclonal (3F121)
  • western blot; human; fig 2
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-70831) was used in western blot on human samples (fig 2). BMC Cancer (2016) ncbi
mouse monoclonal (DCS-31)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology Cdk4 antibody (SCBT, DCS-31) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; 1:1000; fig 1
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, SC23896) was used in western blot on human samples at 1:1000 (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (DCS-35)
  • western blot; rat; 1:500; fig 3
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, SC23896) was used in western blot on rat samples at 1:500 (fig 3). Int J Mol Med (2015) ncbi
mouse monoclonal (DCS-31)
  • western blot; human; 1:1000; fig 1
In order to analyze the anti-cancer effect of fucoidan on human colon cancer cells, Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-56277) was used in western blot on human samples at 1:1000 (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; fig 7
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, SC23896) was used in western blot on human samples (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (DCS-35)
  • western blot; human; fig 3
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-23896) was used in western blot on human samples (fig 3). Cell Cycle (2015) ncbi
mouse monoclonal (DCS-35)
  • western blot; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz Biotechnology, sc-23896) was used in western blot on human samples . BMC Cancer (2014) ncbi
mouse monoclonal (B-10)
  • western blot; human
Santa Cruz Biotechnology Cdk4 antibody (Santa Cruz, sc-166373) was used in western blot on human samples . Exp Cell Res (2014) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:4500; loading ...; fig 4l
Abcam Cdk4 antibody (Abcam, ab137675) was used in western blot on human samples at 1:4500 (fig 4l). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (EPR17525)
  • western blot; mouse; loading ...; fig s4a
Abcam Cdk4 antibody (Abcam, ab199728) was used in western blot on mouse samples (fig s4a). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (EPR2513Y)
  • immunohistochemistry; mouse; loading ...; fig 8b
Abcam Cdk4 antibody (Abcam, ab68266) was used in immunohistochemistry on mouse samples (fig 8b). J Hepatocell Carcinoma (2021) ncbi
domestic rabbit monoclonal (EPR17525)
  • western blot; mouse; loading ...; fig 5c
Abcam Cdk4 antibody (Abcam, ab199728) was used in western blot on mouse samples (fig 5c). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3j
Abcam Cdk4 antibody (Abcam, ab137675) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3j). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EPR17525)
  • western blot; mouse; loading ...; fig 6a
Abcam Cdk4 antibody (Abcam, ab199728) was used in western blot on mouse samples (fig 6a). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit monoclonal (EPR17525)
  • western blot; mouse; 1:2000; fig 5c
Abcam Cdk4 antibody (Abcam, ab199728) was used in western blot on mouse samples at 1:2000 (fig 5c). elife (2020) ncbi
domestic rabbit monoclonal (EPR2513Y)
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam Cdk4 antibody (Abcam, ab68266) was used in western blot on human samples at 1:1000 (fig 4b). Biol Res (2019) ncbi
domestic rabbit monoclonal (EPR17525)
  • western blot; rat; 1:2000; loading ...; fig 6c
Abcam Cdk4 antibody (Abcam, ab199728) was used in western blot on rat samples at 1:2000 (fig 6c). Biosci Rep (2018) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • western blot; bovine; 1:3000; fig 4c
Novus Biologicals Cdk4 antibody (Novus, NBP1-31308) was used in western blot on bovine samples at 1:3000 (fig 4c). Anim Reprod Sci (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; loading ...; fig 4a
  • immunohistochemistry - paraffin section; cat; 1:100; fig 5e
  • western blot; cat; 1:100; fig 4b
In order to elucidate how feline panleukopenia virus maintains host cells in the S phase, Novus Biologicals Cdk4 antibody (Novus Biologicals, NBP1-31308) was used in western blot on human samples at 1:100 (fig 4a), in immunohistochemistry - paraffin section on cat samples at 1:100 (fig 5e) and in western blot on cat samples at 1:100 (fig 4b). Cell Cycle (2016) ncbi
BD Biosciences
mouse monoclonal (DCS-35)
  • western blot; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, BD Biosciences Cdk4 antibody (BD, 559693) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (97/Cdk4)
  • western blot; human; 1:500
In order to develop a neuregulin-1 overexpressing transgenic mouse model of neurofibroma-malignant peripheral nerve sheath tumor progression, BD Biosciences Cdk4 antibody (BD Biosciences, 610147) was used in western blot on human samples at 1:500. Am J Pathol (2013) ncbi
Articles Reviewed
  1. Zhao J, Xu J, Yang T, Yu X, Cheng C, Zhang T, et al. Expression, purification and characterisation of a human anti-CDK4 single-chain variable fragment antibody. BMC Biotechnol. 2021;21:71 pubmed publisher
  2. Xia R, Liu T, Li W, Xu X. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clin Transl Med. 2021;11:e383 pubmed publisher
  3. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  4. Gao L, Meng J, Yue C, Wu X, Su Q, Wu H, et al. Integrative analysis the characterization of peroxiredoxins in pan-cancer. Cancer Cell Int. 2021;21:366 pubmed publisher
  5. Zhang Y, Zhang H, Wu S. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940. J Hepatocell Carcinoma. 2021;8:333-348 pubmed publisher
  6. Cao X, Shu Y, Chen Y, Xu Q, Guo G, Wu Z, et al. Mettl14-Mediated m6A Modification Facilitates Liver Regeneration by Maintaining Endoplasmic Reticulum Homeostasis. Cell Mol Gastroenterol Hepatol. 2021;12:633-651 pubmed publisher
  7. Nishad R, Mukhi D, Singh A, Motrapu M, Chintala K, Tammineni P, et al. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021;12:342 pubmed publisher
  8. Yin Y, Zhou N, Zhang H, Dai X, Lv X, Chen N, et al. Bmi1 regulate tooth and mandible development by inhibiting p16 signal pathway. J Cell Mol Med. 2021;25:4195-4203 pubmed publisher
  9. Buitrago Molina L, Marhenke S, Becker D, Geffers R, Itzel T, Teufel A, et al. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model. Cell Mol Gastroenterol Hepatol. 2021;11:1387-1404 pubmed publisher
  10. Che H, Li J, Li Y, Ma C, Liu H, Qin J, et al. p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle. elife. 2020;9: pubmed publisher
  11. Lin Y, Huang X, Chang K, Liao K, Tsai N. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine. 2020;15:749-760 pubmed publisher
  12. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  13. Fu C, Mao W, Gao R, Deng Y, Gao L, Wu J, et al. Prostaglandin F2α-PTGFR signaling promotes proliferation of endometrial epithelial cells of cattle through cell cycle regulation. Anim Reprod Sci. 2020;213:106276 pubmed publisher
  14. Si J, Ma Y, Bi J, Xiong Y, Lv C, Li S, et al. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. J Exp Clin Cancer Res. 2019;38:481 pubmed publisher
  15. Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer. Aging (Albany NY). 2019;11:7780-7795 pubmed publisher
  16. Kim K, Rana A, Park C. Orai1 inhibitor STIM2β regulates myogenesis by controlling SOCE dependent transcriptional factors. Sci Rep. 2019;9:10794 pubmed publisher
  17. Wang X, Peng P, Pan Z, Fang Z, Lu W, Liu X. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells. Biol Res. 2019;52:34 pubmed publisher
  18. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  19. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed publisher
  20. Liao P, Zeng S, Zhou X, Chen T, Zhou F, Cao B, et al. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding. Mol Cell. 2017;68:1134-1146.e6 pubmed publisher
  21. He D, Ren B, Liu S, Tan L, Cieply K, Tseng G, et al. Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies. Oncogene. 2017;36:3629-3639 pubmed publisher
  22. Li Z, Ivanov A, Su R, Gonzalez Pecchi V, Qi Q, Liu S, et al. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017;8:14356 pubmed publisher
  23. Graziano A, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L, et al. Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 2017;8:13917-13931 pubmed publisher
  24. Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923 pubmed publisher
  25. Poncelet L, Garigliany M, Ando K, Franssen M, Desmecht D, Brion J. Cell cycle S phase markers are expressed in cerebral neuron nuclei of cats infected by the Feline Panleukopenia Virus. Cell Cycle. 2016;15:3482-3489 pubmed publisher
  26. Hrgovic I, Doll M, Kleemann J, Wang X, Zoeller N, Pinter A, et al. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer. 2016;16:763 pubmed
  27. Clay M, Martinez A, Weiss S, Edgar M. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective. Am J Surg Pathol. 2016;40:1647-1652 pubmed
  28. Negis Y, Karabay A. Expression of cell cycle proteins in cortical neurons-Correlation with glutamate-induced neurotoxicity. Biofactors. 2016;42:358-67 pubmed publisher
  29. Liu T, Fang Z, Wang G, Shi M, Wang X, Jiang K, et al. Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells. Oncol Lett. 2016;11:182-188 pubmed
  30. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  31. Xu D, Wang J, Zhou Z, He Z, Zhao Q. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells. Mol Med Rep. 2015;12:7963-70 pubmed publisher
  32. Shain A, Garrido M, Botton T, Talevich E, Yeh I, Sanborn J, et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015;47:1194-9 pubmed publisher
  33. Kennedy A, Vallurupalli M, Chen L, Crompton B, Cowley G, Vazquez F, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015;6:30178-93 pubmed publisher
  34. Saâda Bouzid E, Burel Vandenbos F, Ranchère Vince D, Birtwisle Peyrottes I, Chetaille B, Bouvier C, et al. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas. Mod Pathol. 2015;28:1404-14 pubmed publisher
  35. Yan G, Wang Q, Hu S, Wang D, Qiao Y, Ma G, et al. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Int J Mol Med. 2015;36:1001-11 pubmed publisher
  36. Han Y, Lee J, Lee S. Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep. 2015;12:3446-3452 pubmed publisher
  37. Guha G, Lu W, Li S, Liang X, Kulesz Martin M, Mahmud T, et al. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells. PLoS ONE. 2015;10:e0125322 pubmed publisher
  38. Weingertner N, Neuville A, Chibon F, Ray Coquard I, Marcellin L, Ghnassia J. Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report. Appl Immunohistochem Mol Morphol. 2015;23:230-5 pubmed publisher
  39. Righi A, Gambarotti M, Benini S, Gamberi G, Cocchi S, Picci P, et al. MDM2 and CDK4 expression in periosteal osteosarcoma. Hum Pathol. 2015;46:549-53 pubmed publisher
  40. Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim J, et al. The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells. Cell Cycle. 2015;14:990-1000 pubmed publisher
  41. Oliveira C, de Bock C, Molloy T, Sadeqzadeh E, Geng X, Hersey P, et al. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer. 2014;14:630 pubmed publisher
  42. Brown D, LASSEGUE B, Lee M, Zafari R, Long J, Saavedra H, et al. Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts. PLoS ONE. 2014;9:e96657 pubmed publisher
  43. Wang T, Goodman M, McGough R, Weiss K, Rao U. Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma. Int J Surg Pathol. 2014;22:589-99 pubmed publisher
  44. Machado Neto J, Lazarini M, Favaro P, Franchi G, Nowill A, Saad S, et al. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Exp Cell Res. 2014;324:137-45 pubmed publisher
  45. Val Bernal J, Azueta A, Ortiz Rivas L, Fuentes J, Ballestero R. Incidental lipoma-like hibernoma arising from the adrenal gland: a well-differentiated liposarcoma mimicker. Pathol Res Pract. 2013;209:812-6 pubmed publisher
  46. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed publisher
  47. Yakkioui Y, Temel Y, Creytens D, Jahanshahi A, Fleischeuer R, Santegoeds R, et al. A comparison of cell-cycle markers in skull base and sacral chordomas. World Neurosurg. 2014;82:e311-8 pubmed publisher
  48. Kazmi S, Byer S, Eckert J, Turk A, Huijbregts R, Brossier N, et al. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am J Pathol. 2013;182:646-67 pubmed publisher
  49. Sioletic S, Dal Cin P, Fletcher C, Hornick J. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology. 2013;62:287-93 pubmed publisher
  50. Kashima T, Halai D, Ye H, Hing S, Delaney D, Pollock R, et al. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. Mod Pathol. 2012;25:1384-96 pubmed publisher
  51. Yoshida A, Ushiku T, Motoi T, Beppu Y, Fukayama M, Tsuda H, et al. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype. Am J Surg Pathol. 2012;36:423-31 pubmed publisher
  52. Lee J, Fletcher C. Malignant fat-forming solitary fibrous tumor (so-called "lipomatous hemangiopericytoma"): clinicopathologic analysis of 14 cases. Am J Surg Pathol. 2011;35:1177-85 pubmed publisher
  53. Dujardin F, Binh M, Bouvier C, Gomez Brouchet A, Larousserie F, Muret A, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24:624-37 pubmed publisher
  54. Yoshida A, Ushiku T, Motoi T, Shibata T, Fukayama M, Tsuda H. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant. Am J Surg Pathol. 2010;34:1361-6 pubmed publisher
  55. Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279-88 pubmed publisher
  56. Mariño Enríquez A, Fletcher C, Dal Cin P, Hornick J. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010;34:1122-31 pubmed publisher
  57. Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere Vince D, Dumollard J, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas. Clin Cancer Res. 2009;15:5696-703 pubmed publisher
  58. Horvai A, Devries S, Roy R, O Donnell R, Waldman F. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Mod Pathol. 2009;22:1477-88 pubmed publisher
  59. Nahal A, Meterissian S. Lipoleiomyosarcoma of the rectosigmoid colon: a unique site for a rare variant of liposarcoma. Am J Clin Oncol. 2009;32:353-5 pubmed publisher
  60. Amiot A, Dokmak S, Sauvanet A, Vilgrain V, Bringuier P, Scoazec J, et al. Sporadic desmoid tumor. An exceptional cause of cystic pancreatic lesion. JOP. 2008;9:339-45 pubmed
  61. Horvai A, Schaefer J, Nakakura E, O Donnell R. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas. Mod Pathol. 2008;21:517-24 pubmed publisher
  62. James M, Ray A, Leznova D, Blain S. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol Cell Biol. 2008;28:498-510 pubmed
  63. Al Ayyoubi S, Gali Muhtasib H. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinog. 2007;46:176-86 pubmed
  64. Bosco M, Allia E, Coindre J, Odasso C, Pagani A, Pacchioni D. alpha-fetoprotein expression in a dedifferentiated liposarcoma. Virchows Arch. 2006;448:517-20 pubmed
  65. Mentzel T, Toennissen J, Rutten A, Schaller J. Palmar atypical lipomatous tumour with spindle cell features (well-differentiated spindle cell liposarcoma): a rare neoplasm arising in an unusual anatomical location. Virchows Arch. 2005;446:300-4 pubmed
  66. Coindre J, Hostein I, Maire G, Derré J, Guillou L, Leroux A, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol. 2004;203:822-30 pubmed
  67. Stewart S, Kothapalli D, Yung Y, Assoian R. Antimitogenesis linked to regulation of Skp2 gene expression. J Biol Chem. 2004;279:29109-13 pubmed
  68. Coindre J, Mariani O, Chibon F, Mairal A, De Saint Aubain Somerhausen N, Favre Guillevin E, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256-62 pubmed